# ChatTogoVar

Here is the summary of the variant **rs1057519999** based on the information provided:

---

### 1. **Variant Information (1-1)**  
   - **Rs Number**: rs1057519999  
   - **Gene Name**: TP53 (tumor suppressor p53 gene)  
   - **Known Synonyms**: p53, LFS1  
   - **Chromosome/Position**: Chromosome 17, position 7674247 (GRCh38)  
   - **Known Variants**:  
     - `T>A` (resulting in changes like **Asn239Ile**)  
     - `T>C` (resulting in changes like **Asn239Ser**)  
     - `T>G` (resulting in changes like **Asn239Thr**).

---

### 2. **Relationships to Diseases (1-2)**  
   - The data mentions clinical associations derived from **ClinVar** for multiple variants of rs1057519999.  
     
   #### a) **`T>A` Substitution**:
   - **ClinVar Status**: Classified as **Uncertain Significance (US)**.
   - **Associated Conditions**:
     - **Li-Fraumeni syndrome** ([MedGen](https://www.ncbi.nlm.nih.gov/medgen/): C0085390)  
     - Additional associations are also recorded for cancers like **small cell lung carcinoma** and **pleuropulmonary blastoma** (reported in **MGEND**).  
   - **Pathogenicity Predictions**:
     - **SIFT**: 0.0 (damaging)  
     - **PolyPhen**: 1.0 (probably damaging)  
     - **AlphaMissense**: 0.9897 (high pathogenicity score).

   #### b) **`T>C` Substitution**:
   - **ClinVar Status**: Classified as **Likely Pathogenic (LP)** for multiple cancer-related conditions.  
   - **Associated Conditions**:  
      - **Li-Fraumeni syndrome 1** ([MedGen](https://www.ncbi.nlm.nih.gov/medgen/): C1835398)  
      - **Hereditary cancer-predisposing syndrome** ([MedGen](https://www.ncbi.nlm.nih.gov/medgen/): C0027672)  
      - **Neoplasms**, including **lung adenocarcinoma, breast neoplasms**, and **prostate carcinoma**.
   - **Pathogenicity Predictions**:  
     - **SIFT**: 0.02 (likely damaging, conserved site)  
     - **PolyPhen**: 0.999 (probably damaging)  
     - **AlphaMissense**: 0.7939 (high pathogenicity).  

   #### c) **`T>G` Substitution**:
   - **ClinVar Status**: Mostly considered **Likely Pathogenic (LP)**, with one **Pathogenic (P)** report.  
   - **Associated Conditions**:  
      - **Hereditary cancer-predisposing syndrome** ([MedGen](https://www.ncbi.nlm.nih.gov/medgen/): C0027672).  
      - Neoplasms such as **head and neck squamous cell carcinoma**, **uterine malignancy**, and **lung adenocarcinoma**.  
   - **Pathogenicity Predictions**:
     - **SIFT**: 0.0 (damaging).  
     - **PolyPhen**: 0.545â€“0.999 (potentially damaging).  
     - **AlphaMissense**: 0.9759 (high pathogenicity score).  

---

### 3. **Population Frequencies (1-4)**  
The allele frequencies of `T>C` and `T>G` substitutions are rare in global data from **gnomAD**:  
   - **`T>C` Variant** (Frequency in **Exomes**): 0.000068% (1/1,461,784 alleles)  
   - **`T>G` Variant** (Total Frequency in **Genomes + Exomes**): ~0.00006%.  

Additional data comparing Japanese vs. non-Japanese populations is not currently available through this result.

---

### 4. **Functional and Literature Evidence (1-3 and 1-5)**  
   - **Functional Implications**: All substitutions (T>A, T>C, T>G) occur in coding regions of TP53, affecting amino acid 239 (**Asparagine to Isoleucine/Serine/Threonine**) in certain transcripts. This site in TP53 is associated with the critical tumor suppressor domain.  
   - **GWAS and Phenotypes**: Significant associations for neoplasms and hereditary cancer predispositions as inferred from ClinVar.  

---

### 5. **TogoVar Link (1-6)**  
   - Variant Details Page: [TogoVar - rs1057519999](https://togovar.biosciencedbc.jp/variant/rs1057519999)  

